Top Markets
Coin of the day
Yumanity Therapeutics, Inc. Yumanity Therapeutics, Inc.

Yumanity Therapeutics, Inc.

YMTX
Classifica tra le azioni #28846
Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical... Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical company. Its primary focus lies in the investigation and development of therapeutic solutions for neurodegenerative conditions, particularly those driven by protein misfolding. The firm aims to discover disease-modifying treatments for a range of neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis (ALS), and frontotemporal lobar degeneration. Central to its pipeline is YTX-7739, an innovative small molecule presently in Phase I clinical trials for Parkinson's disease and associated α-synuclein disorders. Additionally, YTX-9184 is undergoing preclinical studies with the goal of treating diverse neurological conditions. The company maintains a license and research collaboration agreement with Merck Sharp & Dohme Corp. Founded in 2014, Yumanity Therapeutics Inc. is headquartered in Boston, Massachusetts.
Prezzo delle azioni
$1.89
Ultima sincronizzazione: 2022-12-16
Capitalizzazione di mercato
$24.38M
Variazione (1 giorno)
8.62%
Variazione (1 anno)
0.00%
Paese
US
Scambia Yumanity Therapeutics, Inc. (YMTX)

Categoria

Storico del prezzo dell'azione per Yumanity Therapeutics, Inc. (YMTX)
Prezzo di chiusura più alto: $1.94 il 2022-12-01

Prezzo di chiusura più basso: $18.35 il 2020-12-01
Storico del prezzo dell'azione di Yumanity Therapeutics, Inc. dal 2020 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2022 -41.89%
2021 -81.82%
2020 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$552.07 41.28%
US
$168.77 504.69%
US
$1.03K 57.19%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH